J.E. Simmons & Co’s AbbVie ABBV Stock Holding History

J.E. Simmons & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+899	New	+$193K	0.13%	67
2026 Q1	–	Sell	-905	Closed	-$207K	–	67
2025 Q4	$207K	Buy	+905	New	+$206K	0.13%	66

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

J.E. Simmons & Co's ABBV Position: Q2 2026 in Review

J.E. Simmons & Co opened a new position in AbbVie (ABBV) in Q2 2026: 899 shares worth $226K. The stake represents 0.13% of the portfolio and ranks #67 among its holdings. This is a return to the name: J.E. Simmons & Co previously reported a position in ABBV as recently as Q4 2025.

J.E. Simmons & Co first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

J.E. Simmons & Co held 899 shares of AbbVie worth $226K as of Q2 2026.
AbbVie was a new J.E. Simmons & Co position in Q2 2026.
AbbVie made up 0.13% of J.E. Simmons & Co's portfolio in Q2 2026, its #67 holding.
J.E. Simmons & Co first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J.E. Simmons & Co's 13F filing for Q2 2026, filed 15 Jul 2026.